These two Australian biotech companies have both completed successful clinical trials today. In turn, boosting their stock prices well into positive territory over a 12-month period.
Biopharmaceutical drug discovery and development small-cap Antisense Therapeutics Ltd [ASX:ANP] have seen a substantial spike in their share price today, up 89.36%.
